肝癌在亚洲是最常见的恶性肿瘤之一,死亡率高,尤其在我国。放疗和化疗对此类肿瘤往往无效,过去认为外科手术切除是首选治疗方法,但因起病较隐匿,患者就诊时大多已属中、晚期,外科手术机会仅10%[1],且术后复发率高。近年来,各种新技术、新疗法不断出现,对肝肿瘤的手术切除形成了 Liver cancer is one of the most common malignancies in Asia with a high mortality rate, especially in our country. Radiotherapy and chemotherapy are often ineffective for such tumors. In the past, surgical resection was considered as the preferred method of treatment. However, due to the insidious onset, most of the patients were already in the middle and late stages of treatment, and the chance of surgery was only 10% [1] High recurrence rate. In recent years, a variety of new technologies, new treatments continue to appear on the surgical removal of liver tumors formed